South Korea: Standigm, a workflow artificial intelligence (AI) drug discovery company, has secured a US$10m investment from Pavilion Capital, a Singapore-based investment institution. The investment will be used for the…

Subscription required

This content is for Subscribers only. To access 4,800+ articles from an archive of 7 years plus data tables on M&A, Equity, Debt and more

Subscribe
Already have an account?

RELATED ARTICLESMORE FROM AUTHOR